Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesh S Palapattu

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
The Journal of Urology|June 21, 2017
Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: YesGanesh S Palapattu
Urologic Oncology|March 12, 2016
Commentary on "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer." Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J, Division of Urologic Oncology, Department of Urology, University of Michigan, MI. N Engl J Med 2014; 371(11):1028-38Ganesh S Palapattu
The Journal of Urology|March 7, 2016
Parsing Multi-omic Data to Understand Urothelial Cell Carcinoma ProgressionGanesh S Palapattu
European Urology|November 17, 2007
Editorial comment on: bladder and urethral sphincter function after radical retropubic prostatectomy: a prospective long-term studyDragan Golijanin, Ganesh S Palapattu
Expert Review of Anticancer Therapy|March 11, 2010
Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trialsGuru Sonpavde, Ganesh S Palapattu
The Journal of Urology|November 21, 2002
Monoclonal antibody therapy for genitourinary oncology: promise for the futureGanesh S Palapattu, Robert E Reiter
Nature Clinical Practice. Urology|May 13, 2006
Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?Ganesh S Palapattu, Edward M Messing
Reviews in Urology|September 21, 2006
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinomaGanesh S Palapattu, Blaine Kristo, Jacob Rajfer
Reviews in Urology|September 21, 2006
Lymph node dissection in patients with kidney cancer: when is it indicated?Ganesh S Palapattu, Hyung L Kim, Arie S Belldegrun
Reviews in Urology|September 21, 2006
Advances in the Treatment of Genitourinary Cancer: Highlights from the 3rd Annual Meeting of the Society of Urologic Oncology, December 13-14, 2002, Washington, DCGanesh S Palapattu, Hyung L Kim, Arie S Belldegrun
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Urology|June 21, 2017
Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: YesGanesh S Palapattu
Urologic Oncology|March 12, 2016
Commentary on "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer." Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J, Division of Urologic Oncology, Department of Urology, University of Michigan, MI. N Engl J Med 2014; 371(11):1028-38Ganesh S Palapattu
The Journal of Urology|March 7, 2016
Parsing Multi-omic Data to Understand Urothelial Cell Carcinoma ProgressionGanesh S Palapattu
European Urology|November 17, 2007
Editorial comment on: bladder and urethral sphincter function after radical retropubic prostatectomy: a prospective long-term studyDragan Golijanin, Ganesh S Palapattu
Expert Review of Anticancer Therapy|March 11, 2010
Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trialsGuru Sonpavde, Ganesh S Palapattu
The Journal of Urology|November 21, 2002
Monoclonal antibody therapy for genitourinary oncology: promise for the futureGanesh S Palapattu, Robert E Reiter
Nature Clinical Practice. Urology|May 13, 2006
Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?Ganesh S Palapattu, Edward M Messing
Reviews in Urology|September 21, 2006
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinomaGanesh S Palapattu, Blaine Kristo, Jacob Rajfer
Reviews in Urology|September 21, 2006
Lymph node dissection in patients with kidney cancer: when is it indicated?Ganesh S Palapattu, Hyung L Kim, Arie S Belldegrun
Reviews in Urology|September 21, 2006
Advances in the Treatment of Genitourinary Cancer: Highlights from the 3rd Annual Meeting of the Society of Urologic Oncology, December 13-14, 2002, Washington, DCGanesh S Palapattu, Hyung L Kim, Arie S Belldegrun
Pageof 14